CMS won't appeal AMP injunction - CMS will not appeal preliminary injunction against average manufacturer price rule. - Drug Topics

ADVERTISEMENT

ADVERTISEMENT

CMS won't appeal AMP injunction
CMS will not appeal preliminary injunction against average manufacturer price rule.


Drug Topics Daily News

The Centers for Medicare & Medicaid Services has decided not to appeal a preliminary injunction that has blocked it from implementing the average manufacturer price rule for Medicaid generic drug reimbursement. In a December hearing, Judge Royce Lamberth granted the injunction after concluding that the case filed by the National Community Pharmacists Association and the National Association of Chain Drug Stores was likely to succeed and that "implementation of this scheme would, in fact, put [pharmacies] out of business." The rule was set to go into effect in January. In the suit, NACDS and NCPA charged that the rule threatened independent pharmacies by sharply reducing reimbursement and that CMS had contradicted numerous aspects of the Social Security Act, including its definition of AMP. CMS now has until March 31 to produce administrative documents on how it developed the rule.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, click here.

 

Keep Connected - Sign Up Now

Subscribe To Drug Topics E-NewsSign up now to receive weekly updates from Drug Topics.

ADVERTISEMENT

Stay Connected to DrugTopics.comweekly email newsletter rss feeds

ADVERTISEMENT

Daily News
PhRMA part of Hurricane Ike response
September 16, 2008
FDA approves clotrimazole
September 16, 2008
Florastor gains shelf space at Duane Reade
September 12, 2008

ADVERTISEMENT



This toolkit contains five components for dealing with the Medicare drug benefit.

• A listing of medication therapy management programs
• Unraveling Medicare Column
• News
• Continuing Education
• Links
For more information, click here.

Celebrate!

ADVERTISEMENT

Source: Drug Topics Daily News,
Click here